Acquiring Company
Kincell Bio
Acquired Company
Cellipont Bioservices
DurhamThe WoodlandsManufacturingBiotechnologyManufacturingBiotechnologyDescription
Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. The merger combines Kincell's expertise in immune-cell technologies with Cellipont's stem cell experience. Kincellis Advanced Therapies will enhance capabilities in the field of regenerative medicine.
Quick answer
Kincell Bio is acquiring Cellipont Bioservices, announced September 17, 2026. Kincell Bio is based in Durham, North Carolina, United States.
- How much did Kincell Bio pay for Cellipont Bioservices?
- The deal value was not disclosed.
- What does Kincell Bio do?
- Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States.
- Where are Kincell Bio and Cellipont Bioservices based?
- Kincell Bio is based in Durham, North Carolina, United States. Cellipont Bioservices is based in The Woodlands, Texas, United States.
- Who are the decision-makers at Kincell Bio?
- Fundz holds 1 contact at Kincell Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Manufacturing and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- BPL Medical Technologies acquires Medec for growth (October 14, 2026)
- eutecma acquires Tempaid for cold chain expansion (September 28, 2026)
- Lifecore Biomedical, Inc. Enters Merger Agreement with Lifecore Inc. (September 28, 2026)
Who to call at Kincell Bio, and when
When Kincell Bio changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Kincell Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kincell Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kincell Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kincell Bio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cellipont Bioservices?
Cellipont Bioservices was acquired by Kincell Bio, based in Durham. The deal was reported on September 17, 2026. Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States. Kincell Bio is privately held and operates in Manufacturing.
When did Kincell Bio acquire Cellipont Bioservices?
Kincell Bio's acquisition of Cellipont Bioservices was reported on September 17, 2026. Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies. This new entity focuses on developing cell therapies and advanced modalities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cellipont Bioservices do?
Cellipont Bioservices is a premier Contract Development and Manufacturing Organization (CDMO) specializing in the advancement of cell therapies. It is privately held, operating in Manufacturing, and is based in The Woodlands.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.